SynthesisBMC infectious diseases2025
Urticaria as a dermatologic manifestation of Giardia infection: a systematic review of clinical, diagnostic, and therapeutic features.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiardiasis is recognized as the most prevalent enteric protozoal infection worldwide. Although gastrointestinal symptoms are the most common manifestations of giardiasis, several studies have reported cases of urticaria associated with this infection. Urticaria is a common mast cell-dependent disorder characterized by wheals, angioedema, or both. The aim of this study was to conduct the first systematic review to comprehensively synthesize the clinical, diagnostic, and therapeutic features of urticaria as a dermatologic manifestation in patients with giardiasis.
methodsThis review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. PubMed/MEDLINE, Web of Science, Scopus, ScienceDirect, and Google Scholar were searched without language restrictions up to 2025 to identify articles reporting patients with urticaria and giardiasis.
resultsThirteen papers describing a total of 23 patients (14 males and 9 females, aged 4 to 56 years) were included. The locations of urticarial lesions varied, involving the head, trunk, and extremities. The duration of urticaria ranged from 8 h to 8 months. Other clinical manifestations reported in the patients included diarrhea, pruritus, abdominal distension, arthropathy, anorexia, headache, vomiting, abdominal pain, and dysphagia. Increased Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), elevated Immunoglobulin E (IgE), eosinophilia, stool examination, and Enzyme-linked immunosorbent assay (ELISA) were among the diagnostic tests utilized. Metronidazole, tinidazole, and quinacrine hydrochloride were the most commonly prescribed medications for treatment.
conclusionsOur review highlights the diversity of clinical presentations and diagnostic approaches, and, for the first time, provides a consolidated resource for clinicians encountering this uncommon extraintestinal manifestation of giardiasis. In the initial evaluation of patients presenting with urticaria and a history of gastrointestinal symptoms, particularly those residing in areas with poor hygiene, potential exposure to contaminated water, or recent travel to such regions, parasitic infections, especially giardiasis, should be considered among the differential diagnoses. By addressing this under-recognized association, our study fills a significant knowledge gap regarding urticaria associated with giardiasis, ultimately facilitating earlier diagnosis, appropriate treatment, and improved patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.